The European Medicines Agency's Approval of New Medicines for Type 2 Diabetes

Diabetes, Obesity and Metabolism- United Kingdom

doi 10.1111/dom.13349

Full Text

Abstract

Available in

Date

Authors

Publisher

Wiley

Related search

The Iterative Development of Medicines Through the European Medicine Agency's Adaptive Pathway Approach

Frontiers in Medicine
Medicine
2019English

Fri0609 European Medicines Agency's Guideline on the Clinical Investigation of Medicinal Products for the Treatment of Rheumatoid Arthritis

2018English

Fundamental Bases of Search of Medicines for Therapy of a Diabetes Mellitus Type 2

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk
Medicine
2013English

Cystic Fibrosis Treatment: A Paradigm for New Pediatric Medicines, Globalization of Drug Development and the Role of the European Medicines Agency

Children
2015English

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

Number of Patients Studied Prior to Approval of New Medicines: A Database Analysis

PLoS Medicine
BiochemistryBiotechnologyMolecular BiologyCell BiologyMedicine
2013English

The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2020English

Developing New Medicines for the Treatment of Pain

Prescriber
Pharmacology
2019English

Nutraceuticals: New Concept of Medicines

International Journal of Trend in Scientific Research and Development
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy